Welcome

SiDMAP, a leader in the field of metabolomics, provides metabolic profiling and phenotyping services and biomarker discovery services to pharmaceutical, biotech and research organizations involved in drug discovery and development and in the study of disease states.

SiDMAP’s unique stable-isotope tracer technology measures metabolic pathway flux to gain unique insight into cell function, enabling scientists to make important project decisions with confidence. Studies in cells and animals can easily translate to clinical studies in humans using our non-radioactive tracers, enabling scientists to answer the most challenging systems biology questions related to disease states such as diabetes, cancer, neurodegenerative diseases and many others. Whether in lead optimization, indicating alternative targets or drug indications, understanding a compound’s mechanism of action or as biomarker discovery tool, SiDMAP will improve your drug discovery process.